Vertex Pharmaceuticals - 2/23

Entry	Author	Date	Location
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos	Erin Kutz	10/13/11	Boston
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C	Luke Timmerman	09/22/11	Seattle
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise	Luke Timmerman	09/19/11	National
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva	Luke Timmerman	09/15/11	Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue	Steve Worland	09/06/11	San Diego
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead	Luke Timmerman	09/06/11	National
The Fall of Pfizer: How Big is Too Big for Pharma Innovation?	Luke Timmerman	08/29/11	National
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO	Luke Timmerman	08/18/11	National
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus	Luke Timmerman	08/08/11	National
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut	Luke Timmerman	07/28/11	Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent	Luke Timmerman	07/18/11	National
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits	Luke Timmerman	07/06/11	San Diego
Brightcove Moving to Boston, Looks to Hire	Gregory T. Huang	07/05/11	Boston
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul	Luke Timmerman	07/05/11	Seattle
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News	Erin Kutz	06/24/11	Boston
Vertex Pays $60M for Alios Drugs, PKE Acquires Dexela, AisleBuyer Grabs $7.5M, & More Boston-Area Deals News	Erin Kutz	06/15/11	Boston
Vertex Adds New HepC Drugs for $60M	Luke Timmerman	06/13/11	Boston
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News	Bruce V. Bigelow	06/09/11	San Diego
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All	Luke Timmerman	06/06/11	National
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News	Erin Kutz	05/27/11	Boston
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug	Luke Timmerman	05/23/11	Boston
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired	Luke Timmerman	05/23/11	National
PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News	Erin Kutz	05/20/11	Boston
Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry	Luke Timmerman	05/17/11	New York
Vertex Signs Boston Lease	Luke Timmerman	05/05/11	Boston
New Health IT Startup Targets Military Programs, Allylix Sniffs New Market for Nootkatone, Biocept Builds Team, & More San Diego Life Sciences News	Bruce V. Bigelow	05/05/11	San Diego
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News	Erin Kutz	04/29/11	Boston
Vertex Wins FDA Panel’s Recommendation for New Hepatitis C Drug	Luke Timmerman	04/28/11	Boston
FDA Panel Meets Today on Vertex HepC Drug	Ryan McBride	04/28/11	Boston
FDA Says Vertex Drug a Wee Bit More Effective Than Advertised; Stock Climbs	Luke Timmerman	04/26/11	Boston
Page 2 of 8	« previous page · next page »

Entry

Author

Date

Location

Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos

Erin Kutz

10/13/11

Boston

Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C

Luke Timmerman

09/22/11

Seattle